Substitution K574A in gp41 decreases the thermostability of HIV-1 functional Env. by Daniel P. Leaman (105329)

Subjects:

A flow chart overview of the mixed ABM model as coded in NetLogo [57]. by Fijnanda van Klingeren (9316647)

Developmental regulation of the decrease in adhesion. by Marco Tarantola (102609)

Subjects:

Baseline characteristics of the study population. by Jesse J. Aarden (6919745)

Inclusion of participants in the study (N = 391). by Jesse J. Aarden (6919745)

Longitudinal association of muscle strength with course of mobility. by Jesse J. Aarden (6919745)

Course of mobility from admission up to three months post-discharge. by Jesse J. Aarden (6919745)

PKCλ KD leads to decreases in CD133-positive cells. by Yuka Nozaki (9115620)

DNA damage induces a pan-nuclear decrease in GFP-lamin A mobility. by Robert Mahen (409641)

Linear mixed model results: Effect of bar height and approach stride number on kinetics at take-off to a jump in agility dogs. by Leena Inkilä (20614460)

Novel chromobox 2 inhibitory peptide decreases tumor progression by Lindsay W. Brubaker (15099942)

Analysis of <i>ATP1A1</i> (12T-ins/del) variants based on blood pressure as a quantitative trait. by Victoria L. Herrera (383897)

Subjects:

Identification of the 12T-ins/del polymorphism in the <i>ATP1A1</i> promoter region and transcriptional activity of <i>ATP1A1</i> promoter variants. by Victoria L. Herrera (383897)

Subjects:

Analysis of ATP1A1 protein expression, blood pressure, heart rate and activity in heterozygous <i>ATP1A1^+/−</i> and wild-type male mice. by Victoria L. Herrera (383897)

Subjects:

Characteristics of the study population. by Victoria L. Herrera (383897)

Subjects:

CsA reduces Flk1 protein expression and significantly decreases the percentages of Flk1+ cells. by Seung-Cheol Choi (686982)

“…(C) Representative flow cytometry profiles showing the decreased percentages of Flk1+ cells in P19 cells treated with 0.32 μM CsA during EB formation for 48 and 96 h, respectively. …”

Changes in baseline T-cell activation markers through week 12 and week 24 according to the linear regression model. a. by Tosi M. Mwakyandile (16408705)

Illustration of the linear setup of a canine cell-free hemoglobin (cfHb) solution processed by hemoperfusion using the Cytosorb^® adsorber. by Kathrin Spiegel (21799784)

Decreased proliferation in <i>AnxA2</i>kd and <i>AnxA5</i>kd cells. by Damian C. Genetos (325684)

Effect of MI to decrease depressive symptoms (fixed-effects model). by Kalayou Kidanu Berhe (9557751)